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Abstract
Background: The prevalence of secondary chronic headache in our population is 0.5%. Data is sparse on these
types of headache and information about utilisation of health care and medication is missing. Our aim was to
evaluate utility of health service services and medication use in secondary chronic headache in the general
population.
Methods: An age and gender stratified cross-sectional epidemiological survey included 30,000 persons 30–44 years
old. Diagnoses were interview-based. The International Classification of Headache Disorders 2nd ed. was applied
along with supplementary definitions for chronic rhinosinusitis and cervicogenic headache. Secondary chronic
headache exclusively due to medication overuse was excluded.
Results: One hundred and thirteen participants had secondary chronic headache. Thirty % had never consulted a
physician, 70% had consulted their GP, 35% had consulted a neurologist and 5% had been hospitalised due to their
secondary chronic headache. Co-occurrence of migraine or medication overuse increased the physician contact.
Acute headache medication was taken by 84% and 11% used prophylactic medication. Complementary and
alternative medicine was used by 73% with the higher frequency among those with than without physician
contact.
Conclusion: The pattern of health care utilisation indicates that there is room for improving management of
secondary chronic headache.
Keywords: Secondary chronic headache, Chronic migraine, Medication-overuse headache, Health care utilisation,
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Background
The WHO initiated ‘Lifting the burden: the global cam-
paign to reduce the burden of headache’ because head-
ache is common, under-diagnosed and undertreated [1-3].
The International Classification of Headache Disorders
2nd edition (ICHD-II) provides diagnostic criteria for
headaches which are divided into primary and secondary
forms [4].
The most common acute secondary headaches are
induced by alcohol, fever, hunger and rhinosinusitis and
are usually paroxysmal [5], but secondary chronic head-
ache (≥ 15 days per month ≥ 3 months or ≥ 180 days/last
year) is also common and medication overuse contri-
butes to the problem [6,7].
Most headaches are self-managed [8], but headache is
also one of the most common reasons for consulting a
general practitioner (GP) and accounts for 4% of all GP
consultations in the UK [9,10]. Approximately 20-30% of
all new referrals to out-patients neurological depart-
ments are due to headache [9-12].
Headache has been suggested to be the most common
new neurological symptom presented [13], and many
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neurological conditions include headache in the symp-
tomatology, thus it also represents an important neuro-
logical differential diagnosis and may cause high use of
health care services.
Epidemiological data on secondary headaches are
largely lacking, and most information are from studies
that have not had a main focus on secondary chronic
headache. The International Headache Society`s classifi-
cation committee encourages further research in order
to provide more knowledge and information of second-
ary headaches [4,14].
We have previously described the management of pri-
mary chronic headaches in the general population [15].
Our aim here was to investigate secondary chronic head-
ache in the general population in order to evaluate utility of
health services and medication use.
Methods
Figure 1 shows a flow-chart of the study. The method
has been described in more detail elsewhere [6,15].
Sampling
A random age-stratified sample of 15 000 men and 15 000
women, 30–44 years old and residing in the 20 eastern
municipalities in Akershus County, was drawn from the
National Personal Registry by Statistics Norway. Akershus
County has both rural and urban areas and is situated in
close proximity to Oslo.
Questionnaire
All persons in the sample received a mailed question-
naire with a standard letter containing information
about the project. Apart from ensuring confidentiality
and emphasizing the importance of participation, it was
stated that the object was to study headache. The ques-
tions ‘How many days during the last month have you
had headache?’ and ‘How many days during the last year
have you had headache?’ were used to screen for chronic
headache. If the questionnaire evoked no response, a
second and subsequently a third reminder were issued.
Clinical interview, physical and neurological examination
The study took place at the Akershus University Hos-
pital in 2005. Persons with self-reported chronic head-
ache who also consented by adding their telephone
number on the questionnaire were invited to a clinical
examination. Self-reported chronic headache was
defined to be headache occurring ≥ 15 days within the
last month and/or headache occurring ≥ 180 days within
the last year. Inclusion required Norwegian languages
skills. Two neurological residents (RBG and KA) experi-
enced in headache diagnostics conducted all interviews
and the physical and neurological examinations. Those
unable to meet at the clinic were interviewed by
telephone.
Headache classification
All headaches were classified according to explicit diag-
nostic criteria of the ICHD-II and its relevant revisions
[4,16-18]. Those with secondary chronic headache exclu-
sively due to medication overuse were excluded.
We defined secondary chronic headache as secondary
headache ≥15 days/month for at least 3 months, as the
ICHD-II do not provide an explicit definition of frequency
for secondary headaches. A more detailed description has
been published elsewhere [6,19].
Chronic post-traumatic headache (CPTH) included
head and whiplash traumas.
Cervicogenic headache (CEH) was classified according
to the criteria of the Cervicogenic Headache International
Study Group, requiring at least three criteria to be fulfilled
not including blockade of the neck due to the non-
interventional nature of our study (Table 1) [20].
Headache attributed to chronic rhinosinusitis (HACRS)
was defined according to the criteria established by the
American Academy of Otolaryngology – Head and Neck
Surgery (Table 2) [21] adding that the symptoms had per-
sisted 12 weeks or more. Those with suspected HACRS
were examined with anterior rhinoscopy and completed
the Sino-Nasal questionnaire (SNOT-20) [22].
Pregnancy related headache is not an ICHD-II diagnosis
unless it is associated with eclampsia. We included 4 women
who experienced headache exclusively during pregnancy.
Two women had chronic headache > 3 months associated
with pre-eclampsia, one had had headache during all 3 preg-
nancies and one had headache during her first pregnancy.
Figure 1 Flow chart of the participation.
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Physician consultation
We defined four levels of contact due to headache, i.e.
none (no physician contact), primary (GP), secondary
(neurologist) and tertiary (hospitalisation). In Norway, a
GP referral is a prerequisite for access to neurologists,
while both GPs and neurologists can refer to the
hospital.
Complementary and alternative medicine (CAM) contacts
The CAM forms queried were acupuncture, chiroprac-
tic, homeopathy, naprapathy, physiotherapy, psychologist
and psychomotor physiotherapy.
Medication use and dependency
We asked about current medication use, and excluded
medication used for other pain conditions. Medication
overuse was defined according to the ICHD-II criteria
for medication overuse headache (i.e. ≥ 15 days per
month for simple analgesics and ≥ 10 days per months
for triptans and ergotamines) [4,17].
To assess dependency-like behaviour in relation to
headache medication, we used the SDS, which includes
five questions designed to measure psychological de-
pendence [23,24]. The questions apply to the headache
medication taken within the last month. Each item is
scored on a 4-point scale (0–3), and the total maximum
score is 15. The method has been described in detail
elsewhere [24].
Data processing
Data from the interviews were directly entered using
SPSS Data Entry 4.0 (SPSS Inc., Chicago, IL, USA) and
statistical analyses were performed using SPSS 20.00
(SPSS Inc., Chicago, IL, USA). For descriptive data,
proportions, means and confidence intervals (CI) are
given. Pearson χ2 test was used for testing significance of
group differences for categorical data, Fisher`s exact test
was used when appropriate. Student`s T-test was used
for numerical data. Significance levels were set at p < 0.05
and 95% CI were calculated. CI and probabilities are not
given when n <5.
Ethical issues
The Regional Committee for Medical Research Ethics
and the Norwegian Social Science Data Services
approved the study. All participants gave informed
consent.
Table 1 Definition of cervicogenic headache [20]
Major criteria I. Symptoms and signs of neck involvement
Ia. Precipitation of head pain, similar to the usually occurring one:
Ia1) by neck movement and/or sustained, awkward head positioning, and/or:
Ia2) by external pressure over the upper cervical or occipital region on the symptomatic side.
Ib. Restriction of the range of motion (ROM) in the neck.
Ic. Ipsilateral neck, shoulder or arm pain of a rather vague, non-radicular nature, or – occasionally – arm pain of a
radicular nature.
II. Confirmatory evidence by diagnostic anaesthetic blockades.
III. Unilaterality of the head pain, without sideshift.
Head pain characteristics IV. Moderate-severe, non-throbbing pain, usually starting in the neck. Episodes of varying duration, or: fluctuating,
continuous pain.
Other characteristics of some
importance
V. Only marginal effect or lack of effect of indomethacin. Only marginal effect or lack of effect of ergotamine and
sumatriptan. Female sex. Not infrequent occurrence of head or indirect neck trauma by history, usually of more
than only medium severity.
Other features of lesser
importance
VI. Various attack-related phenomena, only occasionally present, and/or moderately expressed when present:
a) nausea, b) phono- and photophobia, c) dizziness, d) ipsilateral “blurred vision”, e) difficulties swallowing, f)
ipsilateral oedema, mostly in the periocular area.
It is obligatory that one or more of the phenomena Ia–Ic are present.
Table 2 Definition of rhinosinusitis by the American
Academy of Otolaryngology – Head and Neck Surgery [21]
Major factors Facial pain/pressure
Nasal obstruction/blockage
Nasal discharge/purulence/discolored postnasal drainage
Hyposmia/anosmia
Purulence in nasal cavity on examination
Fever (acute rhinosinusitis)
Minor factors Headache
Fever (all nonacute)
Halitosis
Fatigue
Dental pain
Cough
Ear pain/pressure/fullness
Two major factors or one major and two minor factors are required for the
diagnosis. Of note, facial pain requires another major factor associated with it
for diagnosis, as facial pain plus two minor factors is not deemed sufficient for
diagnoses of rhinosinusitis.
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Table 3 Contact and treatment pattern in relation to secondary headache diagnoses
CPTH without
medication
overuse
(N = 25)
CPTH with
medication
overuse
(N = 22)
All
CPTH
(N = 47)
CEH
without
medication
overuse
(N = 12)
CEH with
medication
overuse
(N = 12)
All
CEH
(N =24)
HACRS without
medication
overuse
(N = 22)
HACRS with
medication
overuse
(N = 24)
All
HACRS
(N = 46)
Other
secondary
chronic
headache
without
medication
overuse
(N = 8)
Other
secondary
chronic
headache
with
medication
overuse
(N = 1)
All
Other
secondary
chronic
headache
(N = 9)
All
secondary
chronic
headaches
without
medication
overuse
(N = 58)
All
secondary
chronic
headaches
with
medication
overuse
(N = 55)
All
secondary
chronic
headaches
(N = 113)
% (n) % (n) % (n) % (n) % (n) % (n) % (n) % (n) %( n) % (n) % (n) % (n) % (n) % (n) % (n)
Contact level
None 28 (7) 18 (4) 23 (11) 42 (5) 25 (3) 33 (8) 36 (8) 17 (4) 26 (12) 63 (5) 0 (0) 56 (5) 41 (24) 18 (10) 30 (34)
Primary 72 (18) 82 (18) 77 (36) 58 (7) 75 (9) 67 (16) 64 (14) 83 (20) 74 (34) 38 (3) 100 (1) 44 (4) 59 (34) 82 (45) 70 (79)
Secondary 40 (10) 59 (13) 49 (23) 8 (1) 50 (6) 29 (7) 27 (6) 29 (7) 28 (13) 0 (0) 100 (1) 11 (1) 28 (16) 44 (24) 35 (40)
Tertiary 8 (2) 5 (1) 6 (3) 0 (0) 8 (1) 4 (1) 5 (1) 4 (1) 4 (2) 0 (0) 100 (1) 11 (1) 5 (3) 5 (3) 5 (6)
Complementary and alternative medicine
Acupuncture 52 (13) 55 (12) 53 (25) 58 (7) 33 (4) 46 (11) 36 (8) 38 (9) 37 (17) 13 (1) 0 (0) 11 (1) 41 (24) 42 (23) 42 (47)
Chiropractic 40 (10) 59 (13) 49 (23) 33 (4) 33 (4) 33 (8) 27 (6) 33 (8) 30 (14) 0 (0) 0 (0) 0 (0) 29 (17) 42 (23) 35 (40)
Homeopathy 12 (3) 23 (5) 17 (8) 25 (3) 8 (1) 17 (4) 14 (3) 17 (4) 15 (7) 0 (0) 0 (0) 0 (0) 12 (7) 16 (9) 14 (16)
Naprapathy 4 (1) 9 (2) 6 (3) 0 (0) 8 (1) 4 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (1) 4 (2) 3 (3)
Physiotherapy 72 (18) 100 (22) 85 (40) 75 (9) 75 (9) 75 (18) 36 (8) 58 (14) 48 (22) 25 (2) 100 (1) 33 (3) 52 (30) 76 (42) 64 (72)
Psychologist 4 (1) 0 (0) 2 (1) 0 (0) 0 (0) 0 (0) 5 (1) 8 (2) 7 (3) 0 (0) 0 (0) 0 (0) 2 (1) 4 (2) 2 (2)
Psychomotor
physiotherapy
4 (1) 5 (1) 4 (2) 0 (0) 8 (1) 4 (1) 0 (0) 4 (1) 2 (1) 0 (0) 0 (0) 0 (0) 2 (1) 5 (3) 4 (4)
Any CAM 76 (19) 100 (22) 87 (41) 75 (9) 83 (10) 79 (19) 64 (14) 67 (16) 65 (30) 25 (2) 100 (1) 33 (3) 64 (37) 82 (45) 73 (82)
Medication use
Acute
medication
68 (17) 100 (22) 83 (39) 75 (9) 100 (12) 88 (21) 82 (18) 100 (24) 91 (42) 50 (4) 100 (1) 56 (5) 69 (40) 100 (55) 84 (95)
Prophylactic
medication
16 (4) 14 (3) 15 (7) 8 (1) 17 (2) 13 (3) 5 (1) 13 (3) 9 (4) 0 (0) 0 (0) 0 (0) 9 (5) 13 (7) 11 (12)
CPTH Chronic post-traumatic headache; CEH Cervicogenic headache; HACRS Headache attributed to chronic rhinosinusitis.
The diagnoses are not mutually exclusive, i.e. one person can have two or more headache diagnoses.
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Results
Participants and headache diagnoses
The questionnaire response rate was 71% and the inter-
view participation rate was 74%. Among the participants,
82% (93/113) had an interview and a physical and neuro-
logical examination at the clinic, whereas 18% (20/113)
had an interview by telephone. Whether the participants
had been interviewed in person or by phone made no dif-
ference to the frequency of the various headache diagno-
ses, medication use, medication overuse, physician or
CAM contact.
A total of 113 participants (22% men and 78% women)
had secondary chronic headaches not exclusively due to
medication overuse.
Forty-two % had CPTH, 21% had CEH, 41% HACRS
and 8% had other secondary chronic headache, i.e.
3 post-craniotomy, 1 diving related, 4 pregnancy related,
and 1 post-meningitis.
The sum exceeds 100%, since the diagnoses are not mu-
tually exclusive. Forty-one% had co-occurrence of mi-
graine and 49% had co-occurrence of medication overuse.
Physician consultation pattern
Table 3 shows the physician contact pattern.
Thirty % (34/113) had never had contact with the health
care system for their secondary chronic headache, while
70% (79/113) had had contact with their GP, 35% (40/113)
had been referred to a neurologist and 5% (6/113) had been
hospitalised for their secondary chronic headache. There
was no gender difference in the physician contact pattern.
Complementary and alternative medicine
Table 3 shows that 73% (82/113) had used CAM for
their secondary chronic headache. Physiotherapy, acu-
puncture and chiropractic were most frequently used.
Physiotherapy was most commonly used in CPTH, CEH
and HACRS, i.e. 85%, 75% and 48%, respectively.
The use of CAM was significantly higher among those
who had consulted a physician compared to those who
had not (84% vs. 47%, p < 0.001).
Co-occurrence of migraine
Co-occurrence of migraine increased health care utilisa-
tion (physician contact (p = 0.043), and hospitalisation
(p = 0.04)).
The overall use of CAM was not significantly influ-
enced by migraine, although there was a tendency for a
higher usage of CAM among people with than without
co-occurrence of migraine.
Use of medication
Acute medication was used by 84%, and 19% used it on
a daily basis. A higher proportion of participants with
than without co-occurrence of migraine used acute
medication (93% vs. 78%, p = 0.024), while there was no
gender difference. People using acute medication had
significantly more physician contact than people not
using acute medication (89% vs. 74%, p = 0.045). People
using acute medication had significantly more CAM use
than people not using acute medication (89% vs. 71%,
p = 0.019).
Contact with physicians was significantly influenced by
medication overuse (82% vs. 59%, p = 0.007), and propor-
tions with none, primary and secondary physician contact
level was also different for those with compared to those
without medication overuse (Figure 2). A higher proportion
of those with than without medication overuse used CAM
(82% vs. 64%, p = 0.032). The distribution of medication
overuse was similar in different subtypes of secondary
chronic headaches. Fifty-eight% overused simple analgesics,
mainly paracetamol and/or ibuprofen and 31% overused
combination analgesics, usually a combination of paraceta-
mol and codeine. Of the latter 53% also overused simple
analgesics. The physician contact level was not influenced
by type of medication overuse. The SDS score was signifi-
cantly higher in those with than without medication over-
use for all levels of physician contact (Figure 3).
Prophylactic treatment was used by 11% (12/113) and
was not influenced by gender or co-occurrence of
migraine.
Discussion
Presentation of main findings
Two-thirds of those with secondary chronic headache
consulted their GP for headache, and half of these had
also consulted a neurologist. Approximately 40% had co-
occurrence of migraine, and approximately 50% had
medication overuse. The majority used acute medication,
Figure 2 Physician contact levels for participants with
secondary chronic headache without (dark grey) or with (light
grey) medication overuse.
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while prophylactic medication was rarely used. Medica-
tion use, medication overuse and high SDS score were
associated with more physician contact, referral and use
of CAM.
Methodological considerations
The present study is based on recruitment from the gen-
eral population. The large sample and high response rate
should ensure representativity. The secondary chronic
headaches CPTH, CEH and HACRS are frequent
enough to ensure accurate descriptive statistics, while
other types of secondary chronic headache are too infre-
quent for statistical analyses. The age range, though it
may exclude some secondary headache types, was
chosen explicitly to focus on a population without too
much co-morbidity of non-headache disorders. Data
from the Norwegian prescription registry indicate a high
increase in drug prescriptions among people above
50 years [25]. This includes medication used for high
blood pressure and pain killers for non-headache pain
which both are is likely to influence the headache
spectrum, a bias that we tried to avoid. Headache diag-
noses are a challenge in people with chronic headache.
To ensure precise diagnostic, two neurological residents
experienced in headache diagnostics conducted all inter-
views. Complicated headache histories were discussed
among the authors before classification. The different
headache diagnoses were equally frequently by the two
interviewers, suggesting that inter-observer variation
was low. Whether the participants had been interviewed
in person or by phone made no difference to the various
outcomes. The ICHD-II classification of the secondary
chronic headaches is a challenge since chronicity is not
defined exhaustively [4]. Likewise, the diagnoses of CEH
are not specific and the diagnosis HACRS is not part of
the ICHD-II classification [20,21].
The data on medication use and health care util-
isation are based on self-reports and therefore open
to recall bias. Health registry data are, however,
often incomplete and not necessarily more precise.
Since there is no systematic registration of CAM,
one has to rely on self-reports.
Physician contact and use of complementary and
alternative medicine
Surprisingly, even though high levels of specialist con-
tact, high medication use, medication overuse and high
proportions of CAM contacts seem to suggest a difficult
headache situation for many of our participants, as many
as 1/3 had no physician contact ever due to their head-
ache. This figure is higher than the corresponding figure
for primary chronic headaches where only 20% had no
such contact [15]. This may be due to low expectations
towards traditional medicine regarding secondary chronic
headache, and/or on the contrary that secondary chronic
headache is expected to be self-treatable. Another possible
explanation might be that the secondary chronic headache
is less disabling than migraine. Co-occurrence of migraine
increased physician contact, and this might explain why
some of those without co-occurrence of migraine rely on
self-treatment for their secondary chronic headache.
The use of CAM was high in our population with sec-
ondary chronic headaches and the use of CAM was sig-
nificantly higher among those who had consulted a
physician compared to those who had not. We have no
specific information on what the GPs and/or neurolo-
gists have done, but it is likely to assume that unsatisfac-
tory pharmacological treatment lead to higher use of
CAM. However, both pharmacological and CAM treat-
ment followed the same pattern i.e. more medication
use correlated with more CAM use. This suggests that
some secondary chronic headache sufferers will try
many treatment options to alleviate their headache.
The most frequent secondary chronic headaches
(CPTH, CEH and HACRS) had surprisingly similar pat-
tern of CAM use despite these are caused by different
pathophysiological mechanisms. Physiotherapy was the
most commonly used strategy in all these three groups,
but to a much higher degree in people with CPTH/CEH
probably due to the fact that these people have more
neck and muscular pain and tenderness than people
with HACRS. Usage of acupuncture, chiropractic and
homeopathy was remarkably similar between the three
groups. In relation to HACRS, this may suggest that this
entity is rarely recognised by people or diagnosed by
SecondaryPrimary*None
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(95
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0
Figure 3 Severity Dependence Scale (SDS) scores in
participants with secondary chronic headache with (black) or
without (dashed) medication overuse vs. contact level. χ2, p <
0.0035 for all contact levels. *Primary contact level in this figure is
defined as GP only (i.e. those participant with only GP contact
without referral) due to illustrative purposes, to avoid overlap of
groups and to allow adequate significant testing with χ2 test.
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either physicians or by those practicing CAM. An alter-
native may be that rhinosinusitis problems are com-
monly present in other conditions with secondary
headache, either by coincidence or by interactions based
on medication use or other causal or interactive relation-
ships such as sensitisation processes. We have previously
described that HACRS may have a better prognosis than
CPTH and especially CEH which support HACRS as a
different entity [19,22]. The improvement among partici-
pants with HACRS was seen especially in those who had
interventions for their rhinosinusitis and who had
reduced their nasal decongestants and their headache
medication overuse [22]. This would seem to support
the presence of HACRS as a chronic headache entity
distinct from CPTH and CEH and that a focus and re-
ferral practice reflecting this by traditional school medi-
cine physicians may give a hope for a more effective
treatment for a group of sufferers from secondary
chronic headache.
Use of medication
Use of acute headache medication is associated with
physician contact and CAM treatment, but even at
the “none” contact level more than 70% used acute
headache medication. Altogether, almost 50% overused
headache medication. In the most revised version of
the headache classification this headache should be
classified as probable MOH until detoxification has taken
place, in which case it would be classified either as MOH
(if improvement is seen) or as the remaining alternative,
secondary chronic headache diagnosis (if no improvement
is seen) [4,16-18]. However in a cross-sectional study such
as the present one, both diagnoses must be given and a
co-morbid situation considered. Medication overuse as
well as SDS score related to the overuse was significantly
associated with increasing contacts with health services,
whether CAM or GPs/neurologists. Medication overuse
seems to be either a marker of a complex chronic headache
requiring increased support from the health services or
causally associated with a worsening of the headache.
The direction of causality of these associations cannot
be determined in a cross-sectional study. The concept
of medication overuse in secondary headaches is still
debatable. Frequent use of medication, for instance,
could be fully justified by a chronic inflammation or
other conditions. In addition, the direction of a possibly
causal association between medication overuse and the
underlying headache becomes even more difficult to
ascertain if the headache is assumed to be secondary to
another, defined organic cause. However, simply the high
co-occurrence of medication overuse seems to suggest
the potential for trying detoxification also in the case
of secondary chronic headaches. We have previously
reported that reduced medication overuse is associated
with improvement of CPTH and HACRS [19,22]. CEH
did not improve after detoxification, but detoxification
did not worsen the headache or have other negative
effects [19].
In contrast to the high level of acute medication use
stands the low level use of prophylactics. Which prophy-
lactics that may be useful in secondary chronic headaches
is not sufficiently described and should be addressed by
further studies.
However, the 41% co-occurrence of migrainous head-
ache may suggest a potential for using migraine prophy-
lactics. It is suggested that migraineurs are undertreated
and a substantial proportion of those who might benefit
from migraine prevention do not receive it [26,27].
Conclusion
Secondary chronic headache is a heterogeneous group of
headache disorders with a high level of health care util-
isation. The high level of neurologist contact, medication
use/overuse and use of CAM indicate that this might be
a complicated group to handle both in primary care and
in neurologists setting. The treatment strategy should be
focused on the type of secondary chronic headache. De-
toxification of medication overuse is recommended and
prophylactic treatment might also be effective, although
the latter has not been documented in clinical trials.
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